Igaunija - igauņu - Ravimiamet

viiv healthcare b.v. - zidovudiin - suukaudne lahus - 10mg 1ml 200ml 1tk

Eiropas Savienība - igauņu - EMA (European Medicines Agency)

novartis europharm ltd - ofatumumab - leukeemia, lümfotsüütne, krooniline, b-rakk - monoklonaalsed antikehad - varem ravimata krooniline lümfoidne leukeemia (cll): arzerra koos kloorambutsiili või bendamustine on näidustatud patsientide raviks cll, kes ei ole eelnevalt saanud ravi ja kellel ei ole õigust fludarabine-põhine ravi. taastekkinud cll: arzerra on näidustatud kombinatsioonis fludarabine ja tsüklofosfamiidi ravi täiskasvanud patsientidel, kellel on taastekkinud cll. tulekindlad cll: arzerra on näidustatud ravi cll patsientidel, kes on tulekindlad, et fludarabine ja alemtuzumab.

Igaunija - igauņu - Ravimiamet

viatris limited - lantaan - närimistablett - 750mg 90tk; 750mg 15tk

Igaunija - igauņu - Ravimiamet

sandoz pharmaceuticals d.d. - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 80mg+12,5mg 90tk; 80mg+12,5mg 28tk; 80mg+12,5mg 98tk; 80mg+12,5mg 20tk; 80mg+12,5mg 280tk; 80mg+12,5mg 30tk; 80mg+12,5mg 100tk; 80mg+12,5mg 15tk; 80mg+12,5mg 56tk; 80mg+12,5mg 7tk; 80mg+12,5mg 10tk; 80mg+12,5mg 50tk; 80mg+12,5mg 60tk

Igaunija - igauņu - Ravimiamet

sandoz pharmaceuticals d.d. - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 160mg+12,5mg 50tk; 160mg+12,5mg 7tk; 160mg+12,5mg 100tk; 160mg+12,5mg 98tk; 160mg+12,5mg 30tk; 160mg+12,5mg 10tk; 160mg+12,5mg 280tk; 160mg+12,5mg 60tk; 160mg+12,5mg 84tk; 160mg+12,5mg 14tk; 160mg+12,5mg 15tk; 160mg+12,5mg 28tk; 160mg+12,5mg 56tk; 160mg+12,5mg 20tk

Igaunija - igauņu - Ravimiamet

elanco animal health gmbh - flumetriin+propoksuur - ravimkaelarihm - 0,28g+1,25g 12.5g 1tk

Igaunija - igauņu - Ravimiamet

sandoz pharmaceuticals d.d. - valsartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 160mg+25mg 14tk; 160mg+25mg 30tk; 160mg+25mg 50tk; 160mg+25mg 10tk; 160mg+25mg 60tk; 160mg+25mg 84tk; 160mg+25mg 28tk; 160mg+25mg 56tk; 160mg+25mg 7tk; 160mg+25mg 98tk; 160mg+25mg 100tk; 160mg+25mg 20tk

Igaunija - igauņu - Ravimiamet

elanco animal health gmbh - flumetriin+propoksuur - ravimkaelarihm - 1,013g+4,5g 45g 1tk

Igaunija - igauņu - Ravimiamet

elanco animal health gmbh - flumetriin+propoksuur - ravimkaelarihm - 0,68g+3,02g 30.2g 1tk

Eiropas Savienība - igauņu - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - idiopaatiline, trombotsütopeeniline purpur - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.